Caricamento...
Activation of CB(2) cannabinoid receptors by AM1241 inhibits experimental neuropathic pain: Pain inhibition by receptors not present in the CNS
We designed AM1241, a selective CB(2) cannabinoid receptor agonist, and used it to test the hypothesis that CB(2) receptor activation would reverse the sensory hypersensitivity observed in neuropathic pain states. AM1241 exhibits high affinity and selectivity for CB(2) receptors. It also exhibits hi...
Salvato in:
| Autori principali: | , , , , , , , , , , |
|---|---|
| Natura: | Artigo |
| Lingua: | Inglês |
| Pubblicazione: |
National Academy of Sciences
2003
|
| Soggetti: | |
| Accesso online: | https://ncbi.nlm.nih.gov/pmc/articles/PMC193595/ https://ncbi.nlm.nih.gov/pubmed/12917492 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1073/pnas.1834309100 |
| Tags: |
Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne! !
|